drugset / Trial / NCT01901159

A Study of RO4995819 to Assess Bioavailability and Safety in Healthy Volunteers

NCT01901159

Phase 1 Completed 52 enrolled Hoffmann-La Roche
RandomizedCrossoverOpen-label

Summary

This randomized, open-label, cross-over study will assess the bioavailability and safety of RO4995819 in healthy volunteers. Volunteers will receive two different formulations (tablet and capsule) of the study drug under fed and fasting conditions.

Timeline

Start
2013-06
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject RO4995819 Small molecule Oral

Indications

No indication recorded.